New drug PORT-77 tested in humans for first time
Knowledge-focused
Completed
This early-stage trial tested the safety of a new drug called PORT-77 in 156 healthy adults. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moves through the body. The goal was to gather initial safety information, not …
Phase: PHASE1 • Sponsor: Portal Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC